XML 24 R4.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Consolidated Statements of Operations and Comprehensive Loss    
Revenue $ 17,913 $ 20,139
Grant income 3,834  
Total revenue and grant income 21,747 20,139
Operating Expenses    
Direct costs 20,649 20,284
Research and development 72,513 73,341
Selling, general and administrative 29,417 31,847
Total operating expenses 122,579 125,472
Operating Loss (100,832) (105,333)
Nonoperating Income and Expense    
Interest income 13,204 17,671
Change in fair value of warrant liabilities (5,146) (4,508)
Interest expense (25) (46)
Other expense (684) (2,977)
Total nonoperating income and expense 7,349 10,140
Income (loss) before income tax expense (benefit) (93,483) (95,193)
Income tax expense (benefit) (8) 1,194
Share of net loss (income) of equity method investee (65) 133
Net Loss Attributable to Common Stockholders (93,410) (96,520)
Other Comprehensive Income 315 598
Comprehensive Loss Attributable to Common Stockholders $ (93,095) $ (95,922)
Basic loss per share $ (0.51) $ (0.54)
Diluted loss per share $ (0.51) $ (0.54)
Weighted average shares outstanding - Basic 184,902,712 179,397,332
Weighted average shares outstanding - Diluted 184,902,712 179,397,332